DarioHealth Corp. - DRIO EV/EBITDA Multiple

DarioHealth Corp. (DRIO) is creating a digital environment for chronic pathology management, where AI and sensors build a powerful database. This chart illustrating the current share price with the 0.00 metric visualizes this process. The business relies on combining remote monitoring with the supply of consumables for diabetics. DarioHealth Corp. (DRIO) maintains stability regardless of economic conditions, focusing on the success of clinical trials.

DRIO DarioHealth Corp: Business Value to Operating Income Before Depreciation in the range 11/23/2025 - 11/12/2026

DRIO (mydario.com): analytical breakdowns and indicator data

- current price and projected stock value:

Stock Price DarioHealth Corporation|DRIO - Broker Consensus Forecast

- issuer market value details:

Market Capitalization DarioHealth Inc|DRIO - Enterprise Value

- issuer book value statistics:

Net Assets per Single Share DarioHealth|DRIO - Accounting Value of Company|Market Capitalization to Book Value Ratio mydario.com|DRIO - Company Total Asset Base

- issuer credit burden and liquidity indicators:

- business earnings and investment ratios data:

DRIO - Company Net Income|Future Profit DarioHealth Corp.|DRIO - Market Price to Net Income Ratio|Forward P/E Multiple DarioHealth Corp.|DRIO - Growth-Adjusted Payback Ratio|Enterprise Value to EBITDA Ratio DarioHealth Inc|DRIO - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) DarioHealth|DRIO - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months mydario.com|DRIO - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year DarioHealth Corp.

Summary company analysis:DarioHealth Corporation DRIO

Integrating AI telemedicine platforms into chronic disease monitoring requires significant capital expenditures, making the EV/EBITDA multiple, adjusted for net debt, a key analytical tool. This indicator compares the total enterprise value, including debt, with operating profit, allowing investors to distinguish genuine asset undervaluation at DarioHealth Corp. (DRIO) from critical insolvency risks when analyzing the price action on the chart.

Competitor analysis

EV/EBITDA Multiple HIMS (Hims)|HNGE: Enterprise Value to Operating Income Before Depreciation|Teladoc Health, Inc. - EV/EBITDA Multiple|TALK - EV/EBITDA Multiple|lifemd.com (LFMD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|American Well Corporation - Business Value to Operating Income Before Depreciation|MGRX (Mangoceuticals Inc.) - EV/EBITDA Multiple|VSee (VSEE) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Mobile-health (MNDR)|ACCD - Company Value to EBITDA|EV/EBITDA Multiple BTCY (Biotricity)|Business Value to Operating Income Before Depreciation LYT|Catasys - EV/EBITDA Multiple|Company Value to EBITDA SHL Telemedicine Ltd.|THRN: EV/EBITDA Multiple